Curriculum Vitae

COLLEGE OF MEDICINE 
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
(last updated 01/23/07)

Deborah J. (Statters) Lockwood, B.M. B.Ch. M.A. M.R.C.P.
Cardiac Arrhythmia Research Institute
1200 Everett Drive, Room 6E103
Oklahoma City, Oklahoma 73104

Phone: 405-271-9696 x37531
Fax: 405-271-7455
E-mail: deborah-lockwood@ouhsc.edu

EDUCATION

1981-1987 University of Oxford Medical School

1973-1980 Kingsbridge Comprehensive School
Kingsbridge, Devon, UK

PROFESSIONAL EXPERIENCE

07/02-present

Assistant Professor of Medicine
Cardiovascular Section
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma

07/00-6/02

Electrophysiology Fellow
Massachusetts General Hospital, Boston

01/99-6/00

Electrophysiology Fellow
Manchester Royal Infirmary, UK
4/97-12/98 Specialist Registrar-Cardiology/General Medicine
Good Hope Hospital, Birmingham UK

10/95-3/97

Cardiology Registrar
Queen Elizabeth Hospital, Birmingham UK

11/92-10/95

British Heart Foundation Junior Cardiology Research Fellow
St. George's Hospital, London UK

03/92-10/92

Cardiothoracic SHO
St. George's Hospital, London UK

08/91-01/92

Cardiology SHO
Bristol Royal Infirmary, Bristol UK

08/90-07/91

General Medicine SHO
Bristol General Hospital, Bristol UK

02/90-07/90

Infectious Diseases SHO
Royal Free Hospital, London UK

08/88-01/90

General Medicine SHO
Mansfield Hospital Group, Notts UK

02/88-07/88

House Surgeon
Churchill Hospital, Oxford UK

08/87-01/88

House Physician
Royal United Hospital, Bath UK


CERTIFICATION OR BOARD STATUS

DEA 07/02/02
BNDD 07/02/02

B.M. B.Ch. Oxford University Medical School

1987

Honors B.A. Physiological Sciences,Oxford

1984

Converted to M.A.

1987

M.R.C.P.

1992

USMLE Basic Science 

10/21/98

USMLE Clinical Science

03/03/99

Clinical skills assessment

09/21/99

USMLE Step 3

12/03/01

Certificate of Completion of Specialist Trainingin Cardiology and General Internal Medicine

07/01/00

NASPexam

May 2001


LICENSES

07/01/00 Massachusetts inactive
07/02/02 Oklahoma active 

RESEARCH AND SCHOLARSHIP

  1. Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolation Using the AtriCure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation. IRB#12421 IDE#G050028/S001

    Co-Principle Investigators: Deborah J. Lockwood and Marvin Peyton

    Sponsor: AtriCure, Inc.

     Projected Grant Award: $35,810

    Start Date: 9/1/2005

      End Date 9/30/2015

    Study Objective: The objectives of this study are to: 1) refine the procedure of performing endoscopically assisted pulmonary vein isolation and LAA excision/exclusion through bilateral mini-thoracotomies; 2) assess the feasibility and safety of performing this surgical procedure in patients with AF of all classifications (paroxysmal, persistent, and permanent); and 3) assess the clinical outcomes in these patients through four months post procedure, with follow-up continuing through ten years after surgery.

  2. Localization of the anterograde and retrograde components of the reentrant circuit of AV nodal reentrant tachycardia. IRB#11255

    Principal Investigator: Deborah J. Lockwood
    Collaborating Investigators: Sunny Po, Warren Jackman, Karen Beckman, Richard Wu

    Sponsor: Cardiac Arrhythmia Research Institute 

     

    Start Date: 3/25/2004

    End Date: Open

    Study Objective: The purpose of this study is to identify the location of the components of the circuit, which allows AV nodal reentry tachycardia to occur. The most common location of one part of the circuit is known, and will provide the primary target of the planned ablation procedure if the diagnosis of AVNRT is confirmed. In some patients ablation at this site does not eliminate the abnormal rhythm and other targets are sought.

  3. Ablation of inappropriate sinus tachycardia syndrome by targeting cardiac neural input. IRB#11468

    Principal Investigator: Deborah J. Lockwood
    Collaborating Investigators: Sunny Po, Warren Jackman, Karen Beckman, Richard Wu

    Sponsor: Cardiac Arrhythmia Research Institute

    Start Date: 6/7/2004

     End Date: Open

    Study Objective: The purpose of this study is to determine whether radiofrequency catheter ablation, targeting the nerve that stimulates the sinus node, can effectively and safely reduce the sinus node rate and reduce symptoms of palpitations.

  4. ATTRAC II Study: Arrhythmia Treatment with a Thermocouple Radiofrequency Ablation Catheter-Remote Protocol IRB#11949 IDE#G020129 C7028301

    Principal Investigator: Karen Beckman and Hiroshi Nakagawa
    Collaborating Investigators: Sunny Po, Richard Wu, Deborah Lockwood and Warren Jackman

    Sponsor: Stereotaxis, Inc. Projected Grant Award: $65,630

    Start Date: 6/2/2005 

    End Date: 6/1/2006

    Study Objective: This is a clinical study to evaluate the safety and efficacy of the Hilios II, a 3-magnet Ablation Catheter, with the Cardiodrive Catheter Advancement System, to eliminate Accessory Atrioventricular pathways in patients with overt or concealed WPW, AV nodal re-entrant tachycardia, and creation of complete AV nodal block in patients with difficult to control ventricular response due to an atrial arrhythmia.

  5. Determinants of Catheter Ablation Failure IRB#09585 C3021501

    Principal Investigator: Sunny S. Po
    Collaborating Investigators: Warren Jackman, Karen Beckman, Hiroshi Nakagawa, Richard Wu, Deborah Lockwood

    Sponsor: NIH

    Projected Grant Award: $669,195

    Start Date: 1/22/2004

     End Date: 11/30/2007

    Study Objective: The purpose of this study is to find out the factors causing unsuccessful catheter ablations in approximately 10% of the patients with paroxysmal supraventricular tachycardia.

  6. Mechanisms of Arrhythmias and Long-Term Follow-Up of Patients Undergoing Catheter Ablation. IRB#09343

    Co-Principal Investigators: Warren Jackman and Karen Beckman
    Collaborating Investigators: Sunny Po, Richard Wu and Deborah Lockwood

    Sponsor: Cardiac Arrhythmia Research Institute

    Start Date: 2/25/2001 

    End Date: Open

    Study Objective: The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at this institution, including recurrence of the ablated arrhythmia and any late complications.

  7. NAVI-STARÒ THERMO-COOLÔ Catheter For Ablation of Atrial Fibrillation IRB#10971 IDE#G030138

    Co-Principal Investigators: Warren M. Jackman and Hiroshi Nakagawa
    Collaborating Investigators: Karen J. Beckman, Sunny S. Po, Richard Wu and Deborah Lockwood

    Sponsor: Cardiac Arrhythmia Research Institute 

    Start Date: 10/2003 

    End Date: Open

    Study Objective: The purpose of this research study is to test the safety and effectiveness of an experimental catheter for ablation of atrial fibrillation. This experimental catheter uses a flow of saline through the catheter, which cools the tip, allowing the use of higher power for ablation. The higher power will increase the depth of the ablation and may increase the chance to eliminate the atrial fibrillation.

  8. VERiTAS: Ventricular Electroanatomical mapping to assess the Risk of life Threatening Arrhthmias IRB#10969

    Co-Principal Investigators: Warren Jackman and Hiroshi Nakagawa
    Collaborating Investigators: Karen Beckman, Sunny Po, Richard Wu, Deborah Lockwood, Jorge Saucedo, Thomas Hennebry

    Sponsor: Cardiac Arrhythmia Research Institute

    Start Date: 1/22/2004 

    End Date: Open

    Study Objective: The long-term objectives of this study are to develop criteria, based on an initial LV endocardial map during sinus rhythm, to identify a large group of post MI patients with low LVEF who do not require ICD therapy, and determine whether LV endocardial mapping should be repeated and at which interval of time to identify arrhythmogenic remodeling.

  9. A Clinical Study for the Assessment of Safety and Efficacy of the High Intensity Focused Ultrasound (HIFU) System for Pulmonary Vein Isolation IRB#11126 IDE#G030184 C#7022101

    Principal Investigator: Richard Wu (formerly Warren Jackman)
    Collaborating Investigators: Karen Beckman, Sunny Po, Warren Jackman and Deborah Lockwood

    Sponsor: ProRhythm, Inc.

     Projected Grant Award: $225,170

    Start Date: 1/30/2004 

    End Date: 1/27/2006

    Study Objective: The purpose of this investigation is to establish that the High Intensity Focused Ultrasound System for Pulmonary Vein isolation (HIFU System) is safe and effective as a cardiac ablation device for the electrical isolation of the pulmonary veins in the treatment of paroxysmal and persistent atrial fibrillation.

  10. Focused Circumferential UltraSound for the Treatment of Atrial Fibrillation IRB#12656 IDE#G030184 C# not yet assigned. 

    Principal Investigator: Richard Wu
    Colaborating Investigators: Karen Beckman, Sunny Po, Warren Jackman and Deborah Lockwood

    Sponsor: ProRhythm, Inc.

     Projected Grant Award: $154,806

    Start Date: 6/1/2006 

    End Date: 2/27/07

    Study Objective: This clinical study is a prospective, randomized, controlled, multicenter clinical trial to evaluate the safety and effectiveness of the HIFU PV Ablation system in Pulmonary Vein Isolation procedures for the treatment of atrial fibrillation. The primary endpoint will compare the rate of patient clinical success in the treatment group (using the HIFU system) against the control group (medical therapy with AADs) Secondarily, chronic success and quality of like endpoints shall be evaluated separately.

  11. New Approaches for the Treatment of Supraventricular Tachycardias IRB#11097

    Principal Investigator: Sunny Po

    Sponsor: Cardiac Arrhythmia Research Institute

    Start Date: 10/14/2003 

    End Date:

    Study Objective: The aim of this study is to evaluate success of ventricular rate control with medications in patients with decreased left ventricular function and hypotension.

  12. Implantable Cardioverter Defibrillator Registry for long QT Syndrome (ICD-LQTS): Observational Study IRB#12078 Principal Investigator: Karen Beckman

    Collaborating Investigator: Richard Wu, Deborah Lockwood and Sunny Po

    Sponsor: Cardiac Arrhythmia Research Institute

    Start Date: 3/2005 

    End Date: Open

    Study Objective: To determine the life-saving effectiveness and safety of ICD therapy in people with LQTS, a registry bank will be formed to monitor the clinical experiences of people with PQTS who have an ICD. Information for the registry bank will be obtained via an enrollment questionnaire, and medical information.

  13. NaviStar ThermoCool Evaluation of the Catheter with the Stockert 70 Radiofrequency Generator for Endocardial Ablation in Patients with Typical Atrial Flutter, Condition of Approval Studyt, PMA #P030031

    Principal Investigator: Richard Wu
    Collaborating Investigator: Deborah Lockwood, Sunny Po and Karen Beckman

    Sponsor: Biosense Webster

     Projected Grant Award: $50,000

    Start Date: 6/1/2006  

    End Date:

    Study Objective; Subjects with symptomatic typical atrial flutter will be considered for this condition of approval study. The study will be conducted in up to 30 centers with a minimum of 221 evaluable subjects. The primary objective is to provide additional, corroborative safety and efficacy data for the NaviStar ThermoCool catheter for the treatment for subjects with typical atrial flutter.


PUBLICATIONS

Refereed Journals:

  1. Nakagawa H, Aoyama H, Beckman KJ, Po SS, Wu R, Lockwood D, Spector P, Calame J, Lustgarten DL, Herring L, Hasdemir C, Singh D. Lazzara R, Jackman WM. Relationship between pulmonary vein firing and extent of left atrial-pulmonary vein connection in patients with atrial fibrillation. Circ 2004; 109(12):1523-1529.

  2. Padrini R, Butrous G, Statters D, Camm AJ, Malik M: Morphological algebraic models of the TU-wave patterns in idiopathic long QT syndrome. Int J Cardiol 2001;77(2-3):151-62.

  3.  Montgomery HE, Clarkson P, Dollery CM, Statters DJ, McEwan JR, McKenna WJ, Humphries S: Association of angiotensin-coverting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;96:741-747.

  4. Statters DJ, Malik M. Redwood R, Hnatkova K, Staunton A, Camm AJ: The use of ventricular premature complexes for risk stratification after myocardial infarction in the thrombolytic era. Am J Cardiol 1996;77:133-138.

  5. Lü F, Anderson MH, Statters DJ, Malik M, Camm AJ: Effects of passive tilt and submaximal exercise on spectral heart rate variability in ventricular fibrillation patients without significant structural heart disease. Am Heart J 1995;129:285-290.

  6.  Lü F, Statters DJ, Anderson MH, Malik M, Camm AJ: Relationship of short- and long-term heart rate variability in patients at risk of sudden death. PACE 1994;17:2194-2200.

  7. Statters DJ, Malik M, Camm AJ: QT dispersion: problems with methodology and clinical significance. J Cardiovasc Electrophysiol 1994;5:672-685.

  8. Lü F, Anderson MH, Katritsis D, Sneddon J, Statters DJ, Malik M, Camm AJ: Decreased heart rate variability in survivors of sudden cardiac death not associated with coronary artery disease. Br Heart J 1994;71:16-21.

  9. Lü F, Statters DJ, Gill JS, Katritsis D, Camm AJ: Alteration of the QT/RR relationship in patients with idiopathic ventricular tachycardia. PACE 1994;17:199-206.

  10. Lü F, Statters DJ, Anderson MH, Katritsis D, Camm AJ: Is there a prolonged QT interval in sudden cardiac death survivors with a "normal" QTc? Am Heart J 1994;128:73-76.

  11.  Lü F, Statters DJ, Camm AJ: QT interval dispersion on 12 lead electrocardiogram in normal subjects. Its reproducibility and relation to the T wave. Am Heart J 1994;127:1654-1655.

  12. Lü F, Statters DJ, Hnatkova K, Poloniecki J, Malik M, Camm AJ: Change of the autonomic influence on the heart immediately before the onset of spontaneous idiopathic ventricular tachycardia. J Am Coll Cardiol 1994;24:1515-1522.

Chapters in Books:

Lockwood D, Otomo K, Wang Z, Nakagawa H, Beckman K, Sherlag BJ, Patterson E, Lazzara R, Jackman WJ. Electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia: Implications for the reentrant circuits. Zipes DP, Jalife J, eds, Cardiac Electrophysiology: From Cell to Bedside, 4th Ed. Sanders Elsevier Publishing. 2004:537-557.

Reviews, Abstracts, Editorials:

  1. Nakagawa H, Yokoyama K, Wu R, Po SS, Lockwood D, Beckman KJ, Herring L, Lazzara R, Scherlag BJ, Jackman WM. Comparison of areas of fractionated atrial lpotentials and location of autonomic ganglionated plexi between patients with paroxysmal, persistent and permanent atrial fibrillation. Heart Rhythm 3(5):AB3-5, 2006.

  2. Nakagawa H, Yokoyama K, Wu R, Po SS, Lockwood DJ, Beckman KJ, Herring L, Lazzara R, Jackman WM. Increased inducibility of macroreentrant left atrial tachycardia with addition of autonomic ganglionated plexi ablation to pulmonary vein antrum isolation. Heart Rhythm 3(5):AB18-3, 2006.

  3. Lockwood DJ, Nakagawa H, Scherlag BJ, Peyton M, Lazzara R, Po SS, Wu R, Patterson E, Jackman WM. Ablation of epicardial autonomic ganglionated plexi during minimally invasive surgical ablation of atrial fibrillation. Heart Rhythm 3(5):AB44-6, 2006.

  4. Nakagawa H, Jackman WM, Yokoyama K, Wu R, Beckman KJ, Po SS, Lockwood D, Oza S, Shukla H, Herring L, Lazzara R: Catheter ablation of macroreentrant right and left atrial tachycardia. Heart View 2005;9:P88-93.

  5. Nakagawa H, Jackman WM, Scherlag BJ, Yokoyama K, Wu R, Oza SA, Shukla H, Beckman KJ, Po SS, Lockwood D, Herring L, Lazzara R. Relationship of complex fractionated atrial electrograms during atrial fibrillation to the location of cardiac autonomic ganglionated plexi in patients with atrial fibrillation. Circ 2005;112:II746.

  6. Nakagawa H, Scherlag BJ, Lockwood D, Wolf R, Peyton M, Wu R, Yokoyama K, Po SS, Herring L, Lazzara R, Jackman WM, Armour A. Localization of left atrial autonomic ganglionated plexuses using endocardial and epicardial high frequency stimulation in patients with atrial fibrillation. Heart Rhythm 2005;2:S10.

  7. Nakagawa H, Scherlag BJ, Wu R, Po S, Lockwood D, Yokoyama K, Herring L, Lazzara R, Jackman WM. Addition of selective ablation of autonomic galglia to pulmonary vein antrum isolation for treatment of paroxysmal and persistent atrial fibrillation. Circ 2004;110:III-543.

  8. Nakagawa H, Aoyama H, Foresti S, Holden M, Pitha JV, Wittkampf F, Wu R, Beckman KJ, Po SS, Lockwood D, Lazzara R, Jackman WM. Testing target navigation in magnetic maneuvering system for pulmonary vein isolation and left atrial linear lesions in a canine model catheter. Heart Rhythm 2004;1:S203.

  9. Foresti S, Lockwood D, Po SS, Wu R, Nakagawa H, Beckman KJ, Aoyama H, Herring L, Oza S, Lazzara R, Scherlag BJ, Jackman WM. Two distinct retrograde slow pathways are consistent with rightward and leftward posterior extensions of the AV node. Heart Rhythm 2004;1:S45.

  10. Nakagawa H, Singh D, Beckman KJ, Lockwood D, Po SS, Wu R, Aoyama H, Foresti S, Oza S, Herring L, Calame JD, Lazzara R, Jackman WM. Ablation of unmappable post-MI ventricular tachycardia using substrate mapping during sinus rhythm: predictors for a recurrence. Heart Rhythm 2004;1:S36.

  11. Wu R, Po SS, Beckman KJ, Nakagawa H, Lockwood D, Foresti S, Oza S. Aoyama H, Lazzara R, Jackman WM. Isolated diastolic potentials recorded at sites distant from earliest ventricular activation in idiopathic left ventricular outflow tract tachycardia. Heart Rhythm 2004;1:S7.

  12. Po SS, Beckman KJ, Lockwood D, Nakagawa H, Otomo K, Wu R, Singh D, Calame JD, Herring L, Ashar M,, Lazzara R, Jackman WM. AV nodal reentrant tachycardia requiring ablation from mitral annulus: selection of effective ablation site. PACE 2003;26:979.

  13. Nakagawa H, Aoyama H, Beckman KJ, Po SS, Lockwood D, Wu R, Ashar M, Singh D, Calame JD, Herring L, Lazzara R, Jackman WM. Safety and efficacy of cryo-ablation of epicardial postero-septal accessory pathways within the middle cardiac vein close (<2mm) to a coronary artery. PACE 2003;26:978.

  14. Nakagawa H, Aoyama H, Beckman KJ, Wu R, Lockwood D, Po SS, Ashar M, Singh D. Calame JD, Herring L, Lazzara R, Jackman WM. Incidence and location of the reentrant circuit in macro reentrant left atrial tachycardia following pulmonary vein isolation. PACE 2003;26:970.

  15. Nakagawa H, Wittkampf F, Aoyama H, Holden M, Pitha JV, Foresti S, Beckman KJ, Po SS, Wu R, Lockwood D, Ashar M, Lazzara R, Jackman WM. Pre-clinical canine testing of a novel magnetic catheter maneuvering system for pulmonary vein isolation and radiofrequency left atrial linear lesions. PACE 2003;26:955.

  16. Nakagawa H, Aoyama H, Pitha JV, Lustgarten DL, Foresti S, Calame JD, Beckman KJ, Ashar M, Po SS, Wu R, Lockwood D, Lazzara R, Jackman WM. Pre-clinical canine testing of a novel high intensity, forward-focused ultrasound balloon catheter for pulmonary vein isolation. PACE 2003;26:954.

  17. Singh D, Nakagawa H, Beckman KJ, Calame JD, Lockwood D, Po SS, Wu R, Ashar M. Aoyama H, Herring L, Lazzara R, Jackman WM. Identification and ablation of arrhythmogenic channels during sinus rhythm in patients with unmappable ventricular tachycardia associated with prior myocardial infarction. PACE 2003;26:945.

  18. Statters D, Knatkova K, Nagayoshi H, Lu F, Rowland E, Camm AJ, Malik M. QT interval reproducibility using computer-aided analysis. Eur Heart J 1996;17:279. Presented at 1996 meeting of the European Society of Cardiology.

  19. Montgomery HE, Clarkson P, Dollery C, Prasad K, Hemingway H, Kiernan L, Bishop G,Statters D, Talmud P, Humphries S, McKenna W, McEwan J: The renin-angiotensin system and left ventricular hypertrophy: rat and human studies. Heart 1996;75 Suppl 1:60. Winner of Young Research Worker's Award at 1966 meeting of the British Cardiac Society.

  20. Statters DJ, Lü F, Panagous A, Rowland E: QT interval dynamics and dispersion in the Romano-Ward syndrome. Circulation 1995;92:1681-1682. Presented at the 68thAnnual Scientific Sessions of the American Heart Association.

  21. Statters DJ, Lü F, Panagous A, Malik M, Rowland E, Camm AJ: How does beta-blockade protect patients with congenital long QT syndrome? Br Heart Journal 1995;73:21. Presented at the1995 British Cardiac Society Meeting.

  22. Statters DJ: Electrocardiographic repolarization. Am Heart J 1995;129:1224-1225.

  23. Lü F, Keeling PJ, Gill JS, Statters DJ, McKenna WJ, Camm AJ: Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure. J Am Coll Cardiol 1994;23:392A. Presented at the 43rd Annual Scientific Sessions of the American College of Cardiology.

  24. Lü F, Statters DJ, Slade AK, Malik M, Camm AJ: Change in autonomic influence on the heart immediately before the onset of spontaneous idiopathic ventricular tachycardia. J Am Coll Cardiol 1994;23:322A. Presented at the 43rd Annual Scientific Sessions of the American College of Cardiology.

  25. Statters DJ, Ward D, Camm AJ: Units QTc. Lancet 1993;341:629

  26. Statters DJ, Colaco B: Deafness and vasculitis: Lancet 1991;337:1602-1603.

  27. Statters DJ, Asokan VS, Littlewood SM, and Snape J: Carcinoma of the caecum in a scorbutic patient. Br J Clin Practice 1990;44:738-740. 


TEACHING ACTIVITIES

CCU attending.
Attending for Fellows Arrhythmia Clinic
Teaching of electrophysiology and ablation procedures to EP fellows.
Pacing lecture to Heart Failure group. 
Medical Students PCM II. Examination tutorial.

PROFESSIONAL SERVICE

Clinical
OU Physicians Clinic
CCU attending

INVITED AND SPECIAL LECTURES

Presenter-Tutorial: Heart Rhythm Society annual meeting, Boston. Heart May 19,2006: "Is there still a role for EP testing in ischemic heart disease for secondary prevention"

Presenter-Tutorial: Heart Rhythm Society annual meeting-May 4-7, 2005 New Orleans. Treatment of AF in the Elderly. May 9, 2005: 

Presenter-Tutorial: Heart Rhythm Society annual meeting-May 4-7, 2005 New Orleans. "EP jeopardy and interesting cases" May 7, 2005: 

April 12, 2005: Memphis. Targeting the Autonomic Ganglionated Plexi in the Treatment of Atrial Fibrillation

April 10, 2005: San Francisco AATS meeting: The Basis for Surgical Treatment of AF

January 5, 2005: San Francisco. Targeting the Autonomic Ganglionated Plexi in the Treatment of Atrial Fibrillation

December 10, 2004: Northwestern Memorial Hospital, Chicago. Symposium faculty. Curing Atrial Fibrillation and Preventing Stroke.

December 3, 2004: ACC Louisiana Chapter meeting. New Orleans. New treatments for Atrial Fibrillation.

November 16, 2004: St. Charles Hospital, Bend OR. CME. Current treatments for Atrial Fibrillation.

October 7, 2004: Mercy Clinical Society, OKC. CME. Supra-Ventricular Tachycardia - other than Atrial Fibrillation.

September 24, 2004: Spokane, WA. Cardiology Conference - Catheter-based and surgical-based approaches to the treatment of atrial fibrillation 

August 20, 2004: Cardiol Grand Rounds OUHSC : The role of technology in ablation

April 6 2004: Internal Medicine Core conference - Arrhythmias - 4/6/04

Sept 9, 2003: Stillwater Hospital CME - The Role of New Technology in the treatment of arrhythmias 

Jan 10th 2003: Cardiology Grand Rounds OUHSC. Accessory Pathways: The danger of Certainty

ADMINISTRATION (COLLEGE AND UNIVERSITY SERVICE)
Member of Harrassment Committee 

MEMBERSHIPS, HONORS, AWARDS, AND SPECIAL RECOGNITION
Scholarly, Professional and Scientific Memberships
British Cardiovascular Society
Heart Rhythm Society
Invited Expert Scientific Reviewer and Chair for CDC KO1 review panel June & August 2004

PROFESSIONAL GROWTH AND DEVELOPMENT Medical Grand Rounds
Cardiovascular Grand Rounds
American College of Cardiology annual meeting
American Heart Association annual meeting
Heart Rhythm Society annual meeting
British Cardiovascular Society annual Scientific Sessions

Cardiovascular Grand Rounds, OUHSC, October 2006
Stereotaxis Training - St. Louis, July 26, 2006
Atrial Fib: Mechanisms and New Directions in Therapy, Boston Jan 2006
Controversies in Treatment of Cardiovascular Disease, Oct 2005
Atrial Fibrillation Symposium, Boston January 2005
SCD HeFT symposium, March 2004
IntraCardiac Echocardiography Peer Training, Cleveland Clinic 12-13 Sept 2003
Advanced Course in Catheter Ablation of Arrhythmias OUHSC 4-7 March 2002
NASPE Board Review Course 22-25 September 1999
Medtronic Defibrillator Course 12-14 April 1999 Advanced Life Support 3 day course Burton 1998
Royal Brompton Hospital Nuclear Cardiology 5 day course 1998
Keele University Management for Specialist Registrars 1997
AICD study day at the Royal Society of Medicine 1997
London Chest Hospital TOE 2 day course 1996
Sheffield Angioplasty 3 day course 1996